Clinical Trial: Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118384) titled 'Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients' on June 20.

Brief Summary: To compare the clinical effectiveness of two different sulbactam-based regimens (ampicillin-sulbactam versus cefoperazone-sulbactam) in the treatment of Acinetobacter baumannii infections in critically ill patients.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Acinetobacter Baumannii Infection

Intervention: DRUG: Cefoperazone-sulbactam injection

Two grams of Cefoperazone/sulbactam IV are administered every ...